Cryoport Chosen to Provide Cold Chain Logistics Support to ProteoGenex

Reusable Cryoport shippers will reduce ProteoGenex’ use of consumable dry ice and save its clients more than 50% on shipping and handling costs.

ProteoGenex, Inc., a Culver City, CA-based provider of biological specimens and clinical information, is using cryogenic logistics products from Cryoport, for shipping its biological specimens, including PBMCs, BMMCs, frozen tissue, OCT-embedded tissue, blood serum, blood plasma, whole blood, RNA/DNA, and other bio-fluids.

ProteoGenex is a global company involved in the procurement and distribution of biological materials for the biomedical research community, which encompasses biotechnology, pharmaceutical, government, and academic research organizations.

ProteoGenex will utilize Cryoport's cryogenic logistics solutions for the movement of biologic materials globally from their extensive biorepository to researchers for clinical study and biological research support.

Marina Prilutskaya, Head of Operations of ProteoGenex, Inc., says, "We have chosen to implement Cryoport's advanced cryogenic logistics solutions because of Cryoport's longstanding cold chain logistics expertise and proven ability to manage the challenges of transporting valuable, temperature-sensitive cryogenically frozen materials. Cryoport's solutions offer a safer, more effective and consistent way to transport our biological specimens that will ultimately prevent degradation or loss of our product. By utilizing Cryoport's reusable shippers we will reduce our use of consumable dry ice shipping materials and many of our clients will save over 50 percent on shipping and handling costs."

"Cryoport is working with ProteoGenex's biological specimen business to make thetransition from cold chain shipping using dry ice to Cryoport's cryogenic logistics solutions, which virtually eliminates the risk of degradation during transport through the use of our dry vapor shippers," says Jerrell Shelton, Chief Executive Officer of Cryoport. "As a result, Cryoport is providing ProteoGenex with a more stable, reliable and cost-effective approach to frozen transportation for its high-value frozen life sciences materials and products."

With strategically placed depots in Europe, Asia and North America, Cryoport is able to support cryogenic logistics in more than 90 countries. Cryoport's cold chain logistics solutions monitor temperatures and record the location of packages throughout the entire logistics process. The company provides comprehensive "chain of condition" and "chain of custody" reporting.

Companies in this article
More in Home